1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)-
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)- Basic information
- Product Name:
- 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)-
- Synonyms:
-
- L-Carnitine·HCl (trimethyl-D?, 98%)
- [D9]-Carnitine Chloride
- CAS:
- 2687961-04-0
- MF:
- C7H16ClNO3
- MW:
- 197.66
- Mol File:
- 2687961-04-0.mol
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)- Chemical Properties
- storage temp.
- -20°C
- solubility
- DMF: 15 mg/ml,DMSO: 20 mg/ml,Ethanol: 25 mg/ml,PBS (pH 7.2): 10 mg/ml
- form
- A crystalline solid
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)- Usage And Synthesis
Uses
L-Carnitine-d9 (chloride)e is the deuterium labeled L-Carnitine chloride. L-Carnitine chloride, a highly polar, small zwitterion, is an essential co-factor for the mitochondrial β-oxidation pathway. L-Carnitine chloride functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation. L-Carnitine chloride is an antioxidant. L-Carnitine chloride can ameliorate metabolic imbalances in many inborn errors of metabolism[1][2][3].
Biological Activity
L-Carnitine-d9 is intended for use as an internal standard for the quantification of L-carnitine by GC- or LC-MS. L-Carnitine is a conditionally essential nutrient.1 It is obtained from dietary sources or through the metabolism of lysine and methionine.2,3 L-Carnitine facilitates the transport of long-chain fatty acids into the mitochondrial matrix for β-oxidation, has other diverse roles on metabolism, and is involved in the maintenance of coenzyme A stores. Plasma and/or tissue levels of L-carnitine are decreased in primary L-carnitine deficiency, a disorder characterized by impaired fatty acid oxidation, with symptoms varying depending on whether it is systemic or muscle-specific.1 Serum and tissue levels of L-carnitine are also reduced in secondary L-carnitine deficiencies caused by a variety of hereditary defects or acquired disorders.
References
1.Seim, H., Eichler, K., and Kleber, H.-P.L(-)-Carnitine and its precursor, γ-butyrobetaineNutraceuticals in Health and Disease Prevention217-256(2001) 2.Vaz, F.M., and Wanders, R.J.A.Carnitine biosynthesis in mammalsBiochem. J.361(Pt 3)417-429(2002) 3.Fu, L., Huang, M., and Chen, S.Primary carnitine deficiency and cardiomyopathyKorean. Circ. J.43(12)785-792(2013)
1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-tri(methyl-d3)-, chloride (1:1), (2R)-Supplier
- Tel
- 028-67271278 18628360895
- sales@artisbio.com
- Tel
- 021-64400900 15800436310
- bessey@reertech.com
- Tel
- 021-51600108 13062666369
- sales@isotopechem.com
- Tel
- 021-58000709 15900491054
- info@scrbio.com
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com